INM
Price
$2.64
Change
-$0.04 (-1.49%)
Updated
Jul 25 closing price
Capitalization
5.29M
TTNP
Price
$4.07
Change
-$1.06 (-20.66%)
Updated
Jul 25 closing price
Capitalization
5.41M
Interact to see
Advertisement

INM vs TTNP

Header iconINM vs TTNP Comparison
Open Charts INM vs TTNPBanner chart's image
InMed Pharmaceuticals
Price$2.64
Change-$0.04 (-1.49%)
Volume$40.16K
Capitalization5.29M
Titan Pharmaceuticals
Price$4.07
Change-$1.06 (-20.66%)
Volume$70.39K
Capitalization5.41M
INM vs TTNP Comparison Chart in %
Loading...
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TTNP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INM vs. TTNP commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INM is a Hold and TTNP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (INM: $2.64 vs. TTNP: $4.07)
Brand notoriety: INM and TTNP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INM: 1% vs. TTNP: 230%
Market capitalization -- INM: $5.29M vs. TTNP: $5.41M
INM [@Biotechnology] is valued at $5.29M. TTNP’s [@Biotechnology] market capitalization is $5.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INM’s FA Score shows that 0 FA rating(s) are green whileTTNP’s FA Score has 0 green FA rating(s).

  • INM’s FA Score: 0 green, 5 red.
  • TTNP’s FA Score: 0 green, 5 red.
According to our system of comparison, both INM and TTNP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INM’s TA Score shows that 2 TA indicator(s) are bullish while TTNP’s TA Score has 3 bullish TA indicator(s).

  • INM’s TA Score: 2 bullish, 8 bearish.
  • TTNP’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, TTNP is a better buy in the short-term than INM.

Price Growth

INM (@Biotechnology) experienced а -1.12% price change this week, while TTNP (@Biotechnology) price change was -9.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

INM is expected to report earnings on May 12, 2025.

TTNP is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TTNP($5.41M) and INM($5.29M) have the same market capitalization . TTNP YTD gains are higher at: 24.847 vs. INM (-42.484). TTNP has higher annual earnings (EBITDA): -4.03M vs. INM (-7.86M). INM has more cash in the bank: 4.68M vs. TTNP (1.95M). TTNP has less debt than INM: TTNP (0) vs INM (849K). INM has higher revenues than TTNP: INM (4.92M) vs TTNP (0).
INMTTNPINM / TTNP
Capitalization5.29M5.41M98%
EBITDA-7.86M-4.03M195%
Gain YTD-42.48424.847-171%
P/E Ratio0.01N/A-
Revenue4.92M0-
Total Cash4.68M1.95M241%
Total Debt849K0-
FUNDAMENTALS RATINGS
INM vs TTNP: Fundamental Ratings
INM
TTNP
OUTLOOK RATING
1..100
326
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
9241
P/E GROWTH RATING
1..100
8580
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INM's Valuation (40) in the null industry is somewhat better than the same rating for TTNP (100) in the Pharmaceuticals Major industry. This means that INM’s stock grew somewhat faster than TTNP’s over the last 12 months.

INM's Profit vs Risk Rating (100) in the null industry is in the same range as TTNP (100) in the Pharmaceuticals Major industry. This means that INM’s stock grew similarly to TTNP’s over the last 12 months.

INM's SMR Rating (98) in the null industry is in the same range as TTNP (98) in the Pharmaceuticals Major industry. This means that INM’s stock grew similarly to TTNP’s over the last 12 months.

TTNP's Price Growth Rating (41) in the Pharmaceuticals Major industry is somewhat better than the same rating for INM (92) in the null industry. This means that TTNP’s stock grew somewhat faster than INM’s over the last 12 months.

TTNP's P/E Growth Rating (80) in the Pharmaceuticals Major industry is in the same range as INM (85) in the null industry. This means that TTNP’s stock grew similarly to INM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INMTTNP
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 27 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TTNP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IIIV28.690.19
+0.67%
i3 Verticals
CPB32.66-0.10
-0.31%
The Campbell's Company
MITQ0.75-0.01
-1.15%
Moving iMage Technologies
CLYM1.45-0.03
-2.03%
Climb Bio Inc
XENE30.30-0.71
-2.29%
Xenon Pharmaceuticals

INM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INM has been loosely correlated with TTNP. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if INM jumps, then TTNP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INM
1D Price
Change %
INM100%
-1.49%
TTNP - INM
43%
Loosely correlated
-20.72%
HYPD - INM
39%
Loosely correlated
-5.75%
OMER - INM
36%
Loosely correlated
+6.69%
VTYX - INM
31%
Poorly correlated
-0.62%
PULM - INM
30%
Poorly correlated
+0.18%
More

TTNP and

Correlation & Price change

A.I.dvisor indicates that over the last year, TTNP has been loosely correlated with INM. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if TTNP jumps, then INM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TTNP
1D Price
Change %
TTNP100%
-20.72%
INM - TTNP
44%
Loosely correlated
-1.49%
ORMP - TTNP
28%
Poorly correlated
-3.57%
SPHRY - TTNP
27%
Poorly correlated
N/A
CDTX - TTNP
27%
Poorly correlated
-1.54%
SER - TTNP
26%
Poorly correlated
N/A
More